A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Partner of Industry and Medical Professionals for Ophthalmic Market Data, Primary Research, Independent Perspective, & Objective Analysis
Latest Reports Latest NewsLatest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 350
Comprehensive Pages
- 40
Competitor Profiles
- 11
IOL Categories Forecasted
- 8
Geographic/Economic Breakouts
2022 IOL Market Report: Global Analysis for 2021 to 2027, April, 2022
The “2022 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
This report describes and forecasts performance by region for 11 categories of IOLs: commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs.
Latest Industry News & Trends
8/12/2022
BreakingCornealDeals
Lions Eye Institute to Acquire Top Eye Bank SightLife
Lions Eye Institute for Transplant and Research announced Aug. 10 that it would acquire SightLife, the world’s leading nonprofit eye bank. Combined, the two nonprofits would create the largest eye ...
8/12/2022
BreakingCataractGlaucomaIOLRevenueSurgical
Q2-2022 Ophthalmic Revenue Roundup for Alcon, Horizon, STAAR, Aerie, Harrow, and Six Others
Alcon reported Aug. 9 that its Q2-2022 net sales totaled $2.2 billion, a 5 percent increase over $2.1 billion in Q2-2021. Surgical net sales for implantables, consumables, and equipment/other were ...
8/12/2022
BreakingClinical TrialRetina
Kodiak RVO Candidate Dosed Every Other Month Hits Primary Phase III Endpoint in BCVA vs. Monthly Aflibercept
Kodiak Sciences announced Aug. 8 that its BEACON Phase III study of KSI-301 (tarcocimab), its novel antibody biopolymer conjugate, met the primary endpoint of non-inferior change from baseline in v...
8/12/2022
BreakingDry EyeRegulation
Novaliq Submits US NDA for CyclASol Cyclosporine Drop in Dry Eye
Novaliq, of Heidelberg, Germany, announced Aug. 9 that it had submitted a new drug application (NDA) to the US FDA seeking approval for CyclASol (cyclosporine ophthalmic solution) for dry eye. Cycl...
8/12/2022
BreakingIndustryRetina
ProQR Seeks Partner to Move Ophthalmology Portfolio Forward
Netherlands-based ProQR Therapeutics announced Aug. 11 that it would seek out a strategic partner to move its ophthalmology programs forward, while it focuses on its Axiomer RNA-editing technology ...
8/12/2022
BreakingCataractSurgical
Orbis Returns to In-Person Training Aboard Flying Eye Hospital in Texas
Orbis International, with support from Alcon, resumed in-person training Aug. 8 aboard its Flying Eye Hospital in Fort Worth, Texas. Over two weeks, Orbis’ clinical staff and volunteer faculty, alo...
8/12/2022
BreakingClinical TrialDry Eye
Tarsus Begins Phase IIa Trial of TP-03 for Demodex MGD
Tarsus Pharmaceuticals announced Aug. 5 that it had enrolled the first patient in a Phase IIa trial of TP-03 (lotilaner ophthalmic solution, 0.25%) for the treatment of meibomian gland dysfunction ...
8/12/2022
BreakingCataractClinical TrialPharma
Formosa, AimMax See Positive Results in Second Phase III Trial of Post-cataract Inflammation, Pain Candidate
Formosa Pharmaceuticals and AimMax Therapeutics reported positive topline results Aug. 9 from the second of two pivotal Phase III studies of APP13007, a novel ophthalmic nanosuspension of the corti...
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register TodayMarket Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Over 500 Clients, Large & Small, Have Trusted Market Scope Data & Analysis
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.